Publicaciones en las que colabora con NORBERTO ORTEGO CENTENO (31)

2023

  1. Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis

    Journal of Autoimmunity, Vol. 140

2021

  1. Genomic Risk Score impact on susceptibility to systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 1, pp. 118-127

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

  2. A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis /692/699/1670 /692/4023/1670/595 article

    Scientific Reports, Vol. 7, Núm. 1

  3. Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort

    Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1337-1338

  4. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

    Scientific Reports, Vol. 7

2016

  1. Genetic analysis with the immunochip platform in Behçet disease. Identification of residues associated in the HLA class I region and new susceptibility loci

    PLoS ONE, Vol. 11, Núm. 8

  2. Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

  2. Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus

    Arthritis and Rheumatology

2013

  1. A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75

  2. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 602-607

  3. Evidence of association of the NLRP1 gene with giant cell arteritis

    Annals of the Rheumatic Diseases

  4. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886

2012

  1. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators

    Arthritis and Rheumatism, Vol. 64, Núm. 1, pp. 264-271

  2. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population

    Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70

  3. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279

  4. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 1, pp. 114-119